New York, United States
New Science Ventures, LLC (NSV) is a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value. NSV invests in companies using science-based innovations to address market needs in Life Sciences (pharmaceuticals, biologics, medical devices, and diagnostics) and Information Technology (e.g., high-performance semiconductors, cellular infrastructure, sensor networks, enterprise software, and storage) sectors. NSV was founded in 2004 by Somu Subramaniam, Managing Partner, and Tom Lavin, Partner, and has invested over $500 million in early, mid- and late stage companies located in the U. S., Europe, India and China.
54
Total Investments
37
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Funding Stage
Series A +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About New Science Ventures
Recent Investments (54)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | May 2024 | |
| Venture Round | •••••• | Feb 2023 | |
| Series B | •••••• | Nov 2022 | |
| Angel Round | •••••• | Jul 2022 | |
| Series B | •••••• | Mar 2022 | |
•••• ••••
|
Series C | •••••• | Dec 2021 |
|
•••• ••••
|
Series D | •••••• | Nov 2021 |
|
•••• ••••
|
Series B | •••••• | Oct 2021 |
|
•••• ••••
|
Series A | •••••• | Jun 2021 |
|
•••• ••••
|
Series B | •••••• | Jun 2021 |
Latest News
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
